These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23752663)

  • 21. Regional variation in use of a new class of antidiabetic medication among medicare beneficiaries: the case of incretin mimetics.
    Marcum ZA; Driessen J; Thorpe CT; Donohue JM; Gellad WF
    Ann Pharmacother; 2015 Mar; 49(3):285-92. PubMed ID: 25515869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receipt of Overlapping Opioid and Benzodiazepine Prescriptions Among Veterans Dually Enrolled in Medicare Part D and the Department of Veterans Affairs: A Cross-sectional Study.
    Carico R; Zhao X; Thorpe CT; Thorpe JM; Sileanu FE; Cashy JP; Hale JA; Mor MK; Radomski TR; Hausmann LRM; Donohue JM; Suda KJ; Stroupe K; Hanlon JT; Good CB; Fine MJ; Gellad WF
    Ann Intern Med; 2018 Nov; 169(9):593-601. PubMed ID: 30304353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
    Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
    Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries.
    Sumarsono A; Sumarsono N; Das SR; Vaduganathan M; Agrawal D; Pandey A
    JAMA Netw Open; 2020 Feb; 3(2):e200181. PubMed ID: 32108893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of county-level socioeconomic status on brand-name prescriptions in Medicare part D: A cross-sectional Study.
    Volpi C; Shehadeh F; Mylonakis E
    Medicine (Baltimore); 2020 Feb; 99(9):e19271. PubMed ID: 32118735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual use of Department of Veterans Affairs and medicare benefits and use of test strips in veterans with type 2 diabetes mellitus.
    Gellad WF; Zhao X; Thorpe CT; Mor MK; Good CB; Fine MJ
    JAMA Intern Med; 2015 Jan; 175(1):26-34. PubMed ID: 25383920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in Medicare Part D coverage of generics with equivalent brand-name drugs.
    Dusetzina SB; Cubanski J; Roberts AW; Hoadley J; True S; Nshuti L; Neuman T
    Am J Manag Care; 2021 Jul; 27(7):283-288. PubMed ID: 34314117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Private expenditures on brand name prescription drugs after generic entry.
    Balaban DY; Dhalla IA; Law MR; Bell CM
    Appl Health Econ Health Policy; 2013 Oct; 11(5):523-9. PubMed ID: 23979876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Association between Industry Payments and Brand-Name Prescriptions in Otolaryngologists.
    Morse E; Hanna J; Mehra S
    Otolaryngol Head Neck Surg; 2019 Oct; 161(4):605-612. PubMed ID: 31547772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
    Gagne JJ; Choudhry NK; Kesselheim AS; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
    Ann Intern Med; 2014 Sep; 161(6):400-7. PubMed ID: 25222387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid dispensing and overlap in veterans with non-cancer pain eligible for Medicare Part D.
    Suda KJ; Smith BM; Bailey L; Gellad WF; Huo Z; Burk M; Cunningham F; Stroupe KT
    J Am Pharm Assoc (2003); 2017; 57(3):333-340.e3. PubMed ID: 28408172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescription Drug Spending and Medication Adherence Among Medicare Beneficiaries with Heart Failure.
    McGee BT; Phillips V; Higgins MK; Butler J
    J Manag Care Spec Pharm; 2019 Jun; 25(6):705-713. PubMed ID: 31134861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should Medicare adopt the Veterans Health Administration formulary?
    Frakt AB; Pizer SD; Feldman R
    Health Econ; 2012 May; 21(5):485-95. PubMed ID: 21506191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of dual drug benefit use among veterans with dementia enrolled in the Veterans Health Administration and Medicare Part D.
    Schleiden LJ; Thorpe CT; Cashy JP; Gellad WF; Good CB; Hanlon JT; Mor MK; Niznik JD; Pleis JR; Van Houtven CH; Thorpe JM
    Res Social Adm Pharm; 2019 Jun; 15(6):701-709. PubMed ID: 30236896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sending The Wrong Price Signal: Why Do Some Brand-Name Drugs Cost Medicare Beneficiaries Less Than Generics?
    Dusetzina SB; Jazowski S; Cole A; Nguyen J
    Health Aff (Millwood); 2019 Jul; 38(7):1188-1194. PubMed ID: 31260351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generic and Brand-Name Thyroid Hormone Drug Use Among Commercially Insured and Medicare Beneficiaries, 2007 Through 2016.
    Ross JS; Rohde S; Sangaralingham L; Brito JP; Choi L; Dutcher SK; Graham DJ; Jenkins MR; Lipska KJ; Mendoza M; Qiang Y; Wang Z; Wu Y; Yao X; Shah ND
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2305-2314. PubMed ID: 30690529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition.
    Dickson SR; Kent T
    JAMA Netw Open; 2021 Nov; 4(11):e2133451. PubMed ID: 34779844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Encouraging generic use can yield significant savings.
    Zimmerman C
    Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
    Luo J; Seeger JD; Donneyong M; Gagne JJ; Avorn J; Kesselheim AS
    JAMA Intern Med; 2016 Sep; 176(9):1317-23. PubMed ID: 27367749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.
    Raimond VC; Feldman WB; Rome BN; Kesselheim AS
    Milbank Q; 2021 Mar; 99(1):240-272. PubMed ID: 33751664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.